# Apimeds Pharmaceuticals US, Inc. (APUS) — merger/definitive [completed]
Source: SEC API (secapi.ai) · situation sit_2500ee6d43f004f36d05 · retrieved 2026-08-12T21:26:50.468Z

## Overview
Apimeds Pharmaceuticals US, Inc. is a Delaware corporation that completed a reverse merger with MindWave Innovations Inc., a digital asset treasury solutions provider specializing in Bitcoin infrastructure, AI-driven yield generation, and blockchain-integrated operations powered by its native $NILA token.

On December 1, 2025, Apimeds Pharmaceuticals US, Inc. completed a reverse merger with MindWave Innovations Inc., with MindWave designated as the accounting acquirer. Under the merger agreement, MindWave's existing stockholders received Series A convertible preferred stock of Apimeds, resulting in the MindWave holders collectively holding 90.9% of Apimeds' equity capital on an as-converted basis as of the closing date. Apimeds is the legal surviving entity and continues as the reporting company.

## Terms
- Counterparty: MindWave Innovations Inc. · Consideration: stock · Stake: 90.9%

## Key dates
- Completed 2025-12-01

## Timeline
- 2026-02-17 · 425 (0001213900-26-017331): 425 - Apimeds Pharmaceuticals US, Inc. — *Apimeds Pharmaceuticals US, Inc. is a Delaware corporation that completed a reverse merger with MindWave Innovations Inc., a digital asset treasury solutions provider specializing in Bitcoin infrastructure, AI-driven yield generation, and blockchain-integrated operations powered by its native $NILA token.* On December 1, 2025, Apimeds Pharmaceuticals US, Inc. completed a reverse merger with MindWave Innovations Inc., with MindWave designated as the accounting acquirer. Under the merger agreement, MindWave's existing stockholders received Series A convertible preferred stock of Apimeds, resulting in the MindWave holders collectively holding 90.9% of Apimeds' equity capital on an as-converted basis as of the closing date. Apimeds is the legal surviving entity and continues as the reporting company.
  https://www.sec.gov/Archives/edgar/data/1894525/0001213900-26-017331.txt

## Citations
- 0001213900-26-017331 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000121390026017331